A 10-Year-Old Boy with a History of Mild, Persistent Asthma

A 10-year-old boy with a history of mild, persistent asthma is brought to the office for follow-up.  His asthma symptoms are controlled with an inhaled beta-agonist and inhaled glucocorticoid therapy.  There is no family history of asthma, but both his parents and older brother have short stature.  The patient's mother is concerned about the use of glucocorticoids because she read on the Internet that they cause growth retardation.  The patient's glucocorticoid medication is stopped, and he is started on a trial of inhaled cromolyn.  Which of the following is the most likely site of action of this new medication?

A) A
B) B
C) C
D) D
E) E
F) F

Correct Answer:

Verified

Unlock this answer now
Get Access to more Verified Answers free of charge

Access For Free